Bile Acid Therapy in Pediatric Hepatobiliary Disease: The Role of Ursodeoxycholic Acid

This publication has 141 references indexed in Scilit:

• Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys
  Published by Elsevier ,2002
• A new cause of progressive intrahepatic cholestasis: 3β-Hydroxy-C27-steroid dehydrogenase/isomerase deficiency
  The Journal of Pediatrics, 1994
• Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurocheno‐deoxycholate in rats
  Liver International, 1993
• Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis
  Digestive Diseases and Sciences, 1993
• Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis
  The Journal of Pediatrics, 1992
• Protective effect of tauroursodeoxycholate against chenodeoxycholate-induced damage to cultured rabbit gastric cells
  Digestive Diseases and Sciences, 1991
• Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis
  The Journal of Pediatrics, 1990
• Bile acid-induced liver toxicity: Relation to the hydrophobic-hydrophilic balance of bile acids
  Medical Hypotheses, 1986
• Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up
  Digestive Diseases and Sciences, 1985
• Tauroursodeoxycholate prevents taurocholate induced cholestasis
  Life Sciences, 1982